Experimental therapy of human glioma by means of a genetically engineered virus mutant

Science

Volumn 252, Issue 5007, 1991, Pages 854-856

  Martuza, Robert L ^a   Malick, Amy ^a   Markert, James M ^a,c   Ruffner, Katherine L ^b   Coen, Donald M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FOSCARNET; VIDARABINE;

ANIMAL MODEL; ARTICLE; BRAIN TUMOR; GLIOMA; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MOUSE; MUTANT; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH; VIRUS;

ANIMAL; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FOSCARNET; GLIOMA; MICE; MICE, NUDE; MUTAGENESIS; PHOSPHONOACETIC ACID; SIMPLEXVIRUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYMIDINE KINASE; VIDARABINE; VIRAL VACCINES;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; MUS MUSCULUS;

EID: 0025864440     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1851332     Document Type: Article

References (0)